1. Home
  2. IQ vs CYRX Comparison

IQ vs CYRX Comparison

Compare IQ & CYRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

IQ

iQIYI Inc.

HOLD

Current Price

$1.01

Market Cap

872.3M

ML Signal

HOLD

Logo CryoPort Inc.

CYRX

CryoPort Inc.

HOLD

Current Price

$16.84

Market Cap

814.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
IQ
CYRX
Founded
2009
1999
Country
China
United States
Employees
N/A
1100
Industry
Consumer Electronics/Video Chains
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
872.3M
814.9M
IPO Year
2017
2008

Fundamental Metrics

Financial Performance
Metric
IQ
CYRX
Price
$1.01
$16.84
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
2
8
Target Price
$2.91
$13.31
AVG Volume (30 Days)
9.0M
440.9K
Earning Date
05-18-2026
05-04-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
156.22
EPS
N/A
N/A
Revenue
N/A
$176,177,000.00
Revenue This Year
$0.28
$11.06
Revenue Next Year
$3.54
$8.45
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.86
$7.61
52 Week High
$2.72
$17.20

Technical Indicators

Market Signals
Indicator
IQ
CYRX
Relative Strength Index (RSI) 47.53 61.56
Support Level $0.99 $14.55
Resistance Level $1.23 $16.87
Average True Range (ATR) 0.07 0.55
MACD 0.02 0.10
Stochastic Oscillator 49.98 86.56

Price Performance

Historical Comparison
IQ
CYRX

About IQ iQIYI Inc.

Iqiyi is a leading streaming video-on-demand company in China that generates revenue mostly through a subscription basis. The platform also provides user-generated content to nonpaying users, monetized through ads. The company self-produces much of the subscription content and also generates revenue through content distribution, gaming, and IP licensing. Iqiyi competes directly with Tencent Video, Alibaba's Youku, ByteDance's MangoTV, and Bilibili. The company is 45% and 5% owned by Baidu and Xiaomi, respectively.

About CYRX CryoPort Inc.

CryoPort Inc is a provider of integrated, temperature-controlled supply chain solutions for the life sciences industry, with a focus on supporting the cell and gene therapy market. The company provides services such as temperature-controlled logistics, biostorage, bioservices, cryopreservation solutions, and cryogenic systems manufacturing. It operates through two reportable segments: Life Sciences Services and Life Sciences Products. It generates the majority of its revenue from the Life Sciences Services segment.

Share on Social Networks: